
Copart (CPRT) shares declined 4.1% following its Q4 FY25 report, despite beating earnings estimates with $0.41 per share, as sales of $1.13 billion missed expectations and year-over-year revenue growth decelerated to 5% from a full-year 10%. Investor apprehension stems from this slowing sales momentum and a notable discrepancy where free cash flow is 20% below reported net income, implying a higher effective valuation of approximately 40x on a cash flow basis. Analysts consider the stock overvalued at 33x earnings, deeming its projected 13-14% long-term growth insufficient to justify the current multiple, despite strong Q4 profit expansion.
Copart's (CPRT) fiscal fourth-quarter 2025 results triggered a 4.1% share price decline, as a revenue miss overshadowed an earnings beat. The company reported earnings of $0.41 per share, exceeding the $0.36 analyst consensus, but sales of $1.13 billion fell short of the $1.14 billion forecast. A primary concern for investors is the deceleration in top-line growth to 5% year-over-year in Q4, a significant slowdown from the 10% growth rate posted for the full fiscal year, signaling a potential slowdown in business momentum. While Q4 profit growth was strong at 24%, this is contrasted by significant valuation headwinds. The stock is priced at 33 times earnings, which is difficult to justify against a consensus long-term growth projection of around 13%. Furthermore, a critical discrepancy exists between reported earnings and cash generation, with free cash flow running approximately 20% below net income, effectively raising the valuation multiple to nearly 40x on a free cash flow basis and questioning the quality of reported profits.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly negative
Sentiment Score
-0.60
Ticker Sentiment